News & Events

  • February 22, 2012

    People’s Liberation, Inc. announced the closing of their Private Placement in the amount of $11,500,000. EG&S acted as counsel to the Investor.

  • February 20, 2012

    Superconductor Technologies Inc. announced the closing of their Registered Direct offering in the amount of $4,563,535. EG&S acted as counsel to the placement agent.
     

  • February 15, 2012

    Cardium Therapeutics, Inc. announced the closing of their Registered Direct in the amount of $5,000,000. EG&S acted as counsel to the placement agent.
     

  • February 14, 2012

    Apps Genius Corp announced the closing of their Registered Direct offering in the amount of $1,000,000.  EG&S acted as counsel to the placement agent.

  • February 10, 2012

    Neuralstem, Inc. announced the closing of their Registered Direct offering in the amount of $5,050,000.  EG&S acted as counsel to the placement agent.
     

  • February 10, 2012

    EpiCept Corporation announced the closing of their Registered Direct offering in the amount of $2,000,000. EG&S acted as counsel to the placement agent.
     

  • February 09, 2012

    Advaxis, Inc. announced the closing of their PIPE offering in the amount of $1,047,500. EG&S acted as counsel to the placement agent.
     

  • February 07, 2012

    Spherix Incorporated announced the closing of their Registered Direct offering in the amount of $1,150,001. EG&S acted as counsel to the placement agent.
     

  • February 06, 2012

    Jones Soda Co. announced the closing of their Registered Direct offering in the amount of $3,207,500. EG&S acted as counsel to the placement agent.
     

  • February 03, 2012

    Generex Biotechnology Corporation announced the closing of their PIPE offering in the amount of $2,000,000. EG&S acted as counsel to Generex.
     

  • February 02, 2012

    Hyperdynamics Corporation announced the closing of their Registered Direct offering in the amount of $30,000,000. EG&S acted as counsel to the placement agent.
     

  • January 30, 2012

    Cel-Sci Corporation announced the closing of their Registered Direct offering in the amount of $5,760,000.  EG&S acted as counsel to the placement agent.
     

  • January 20, 2012

    DARA BioSciences, Inc. announced the closing of their Registered Direct offering in the amount of $1,700,000. EG&S acted as counsel to the placement agent.
     

  • January 18, 2012

    NutraCea announced the closing of their PIPE offering in the amount of $870,000. EG&S acted as counsel to NutraCea.
     

  • January 17, 2012

    Barry Grossman gave a presentation on the requirements and methodologies used to Go Private and participated on a panel discussing Privatization of Chinese Companies.

    Click here to view the presentation

  • January 11, 2012

    Ellenoff Grossman & Schole LLP was ranked #4 for issuer representation in IPO transactions  (by number of transactions) for 2011.

    Click here to view the rankings

  • January 04, 2012

    Ellenoff Grossman & Schole LLP was ranked #1 for placement agent representation in PIPE transactions (by number of transactions) for 2011.

    Click here to view the rankings

  • December 30, 2011

    AspenBio Pharma, Inc. announced the closing of their registered direct offering in the amount of $1,637,100.  EG&S acted as counsel to the Placement Agent.
     

  • December 28, 2011

    Oculus Innovative Sciences, Inc. announced the closing of their registered direct offering in the amount of $2,081,100.  EG&S acted as counsel to the Placement Agent.
     

  • December 28, 2011

    Quadrant 4 Systems Corporation announced the closing of their private placement in the amount of $800,000.  EG&S acted as counsel to the Investor.
     

  • December 27, 2011

    Catasys, Inc. announced the closing of their registered direct offering in the amount of $974,999. EG&S acted as counsel to the Placement Agent.
     

  • December 21, 2011

    StemCells, Inc. announced the closing of their underwritten public offering in the amount of $10,000,000. EG&S acted as counsel to the Underwriter.
     

  • December 13, 2011

    PhotoMedex, Inc., a NASDAQ listed company, and Radiancy, Inc., a private Delaware company,  announced the completion of their merger.  Pursuant to the merger, the former stockholders of Radiancy received shares of Photomedex valued on the date of closing at approximately $235 million and collectively own approximately 75% of PhotoMedex, Inc. following the merger. Radiancy became a majority-owned subsidiary of PhotoMedex. EG&S acted as counsel to Radiancy.

  • December 13, 2011

    Cell Therapeutics Inc. announced the closing of their registered direct in the amount of $20,000,000. EG&S acted as counsel to the Placement Agent.

  • December 07, 2011

    Capitol C Holdings LLC announced the completion of its refinancing of senior secured debt with NCB, FSB.  EG&S acted as counsel to Capitol C Holdings.